(Q35053266)

6 August 2017

Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers (English)

1 reference

6 August 2017

Chia-Chyi Liu

2

0 references

Jen-Ren Wang

object named as

Jen-Ren Wang

12

0 references

Szu-Min Hsieh

object named as

Szu-Min Hsieh

10

0 references

author name string

Ai-Hsiang Chou

1

1 reference

6 August 2017

Jui-Yuan Chang

3

1 reference

6 August 2017

Renee Jiang

4

1 reference

6 August 2017

Yi-Chin Hsieh

5

1 reference

6 August 2017

Amanda Tsao

6

1 reference

6 August 2017

Chien-Long Wu

7

1 reference

6 August 2017

Ju-Lan Huang

8

1 reference

6 August 2017

Chang-Phone Fung

9

1 reference

6 August 2017

Ya-Fang Wang

11

1 reference

6 August 2017

Mei-Hua Hu

13

1 reference

6 August 2017

Jen-Ron Chiang

14

1 reference

6 August 2017

Ih-Jen Su

15

1 reference

6 August 2017

Pele Choi-Sing Chong

16

1 reference

6 August 2017

language of work or name

English

0 references

publication date

21 November 2013

1 reference

6 August 2017

1 reference

6 August 2017

8

1 reference

6 August 2017

11

1 reference

6 August 2017

e79783

1 reference

Creative Commons Attribution 3.0 Unported

6 August 2017

start time

21 November 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Immunological evaluation and comparison of different EV71 vaccine candidates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

Production of EV71 vaccine candidates

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

Identification and characterization of a cross-neutralization epitope of Enterovirus 71.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

Virology, epidemiology, pathogenesis, and control of enterovirus 71.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

EV71: an emerging infectious disease vaccine target in the Far East?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

Development of enterovirus 71 vaccines.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

DNA vaccine constructs against enterovirus 71 elicit immune response in mice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

An overview of the evolution of enterovirus 71 and its clinical and public health significance

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

An apparently new enterovirus isolated from patients with disease of the central nervous system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences.

8 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079783

High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079783

Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079783

A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0079783

Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3836818

Selection and characterization of vaccine strain for Enterovirus 71 vaccine development

25 October 2018

1 reference

12 December 2020

Generation of murine monoclonal antibodies which cross-neutralize human enterovirus genogroup B isolates

1 reference

12 December 2020

Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process

1 reference

12 December 2020

Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0079783

Identifiers

DOI

1 reference

6 August 2017

0 references

1 reference

6 August 2017

1 reference